GlaxoSmithKline plc Operating Expenses 2011-2026 | GSK

Annual Operating Expenses GlaxoSmithKline plc

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	16.2 B	34.2 B	33.8 B	33.6 B	34.3 B	20.8 B	32.5 B	31.1 B	30.2 B	31.4 B

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
34.3 B	16.2 B	29.8 B

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Amarin Corporation plc AMRN	171 M	$ 14.67	-0.07 %	$ 6.09 B	Irlanda
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Cabaletta Bio CABA	172 M	$ 2.82	1.44 %	$ 283 M	USA
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.29	-3.01 %	$ 329 M	Britain
CEL-SCI Corporation CVM	26.4 M	$ 3.47	-1.7 %	$ 221 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Denali Therapeutics DNLI	502 M	$ 19.74	-12.17 %	$ 3.25 B	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	142 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	19.3 M	$ 1.09	-9.17 %	$ 22.4 M	Israel
Enochian Biosciences ENOB	189 M	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Equillium EQ	23.6 M	$ 2.06	-	$ 118 M	USA
Esperion Therapeutics ESPR	343 M	$ 2.85	3.26 %	$ 592 M	USA
Eton Pharmaceuticals ETON	43.6 M	$ 23.45	-1.64 %	$ 631 M	USA
China SXT Pharmaceuticals SXTC	5.04 M	$ 1.32	-5.2 %	$ 1.88 M	China
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
CRISPR Therapeutics AG CRSP	668 M	$ 47.55	0.98 %	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	52.2 M	$ 4.45	-1.77 %	$ 853 M	Canada
Allakos ALLK	196 M	-	-	$ 28.6 M	USA